ConductScience.org, home

Trial · NCT07908771

Virtual Reality for Anxiety and Birth Satisfaction During Elective Cesarean Section

NCT07908771, Not applicable, Not yet recruiting, Tarsus University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Virtual Reality for Anxiety and Birth Satisfaction During Elective Cesarean Section. Trials, record NCT07908771. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07908771

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Virtual Reality for Anxiety and Birth Satisfaction During Elective Cesarean Section
NCT number
NCT07908771
Status
Not yet recruiting
Phases
Not applicable
Enrollment
144 participants, estimated
Lead sponsor
Tarsus University
Conditions
Anxiety, Cesarean Section, Birth Satisfaction
Interventions
Virtual Reality Distraction
First posted
2026-11-02
Last updated
2026-11-02

Source ClinicalTrials.gov

Registered outcomes8

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryState AnxietyPreoperatively (before randomization) and 15-30 minutes after completion of surgery, once clinically stableState anxiety will be assessed using the State-Trait Anxiety Inventory - State Subscale (STAI-I), Turkish version. Scores range from 20 to 80; higher scores indicate higher anxiety levels.
SecondaryFace Anxiety ScorePreoperatively (before randomization), intraoperatively (immediately after birth, before first mother-infant contact), and 15-30 minutes after completion of surgery, once clinically stableMomentary anxiety will be assessed using the single-item Face Anxiety Scale (Turkish version). Scores range from 1 to 5; higher scores indicate higher anxiety.
SecondaryCesarean Birth Satisfaction6-8 hours postpartumCesarean birth satisfaction will be assessed using the 11-item Cesarean Birth Satisfaction Scale. Scores range from 11 to 55; higher scores indicate greater satisfaction.
SecondarySystolic Blood PressurePreoperatively (before randomization) and 15-30 minutes after completion of surgery, once clinically stableSystolic blood pressure (mmHg) will be measured and recorded on the Vital Signs Monitoring Form.
SecondaryDiastolic Blood PressurePreoperatively (before randomization) and 15-30 minutes after completion of surgery, once clinically stableDiastolic blood pressure (mmHg) will be measured and recorded on the Vital Signs Monitoring Form.
SecondaryHeart RatePreoperatively (before randomization) and 15-30 minutes after completion of surgery, once clinically stableHeart rate (beats per minute) will be measured and recorded on the Vital Signs Monitoring Form.
SecondaryRespiratory RatePreoperatively (before randomization) and 15-30 minutes after completion of surgery, once clinically stableRespiratory rate (breaths per minute) will be measured and recorded on the Vital Signs Monitoring Form.
SecondaryPeripheral Oxygen Saturation (SpO₂)Preoperatively (before randomization) and 15-30 minutes after completion of surgery, once clinically stablePeripheral oxygen saturation (%) will be measured by pulse oximetry and recorded on the Vital Signs Monitoring Form.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07908771

GET https://conductscience.org/api/trials/v1/NCT07908771/registered